Medadvisor (Australia) Performance
| MDR Stock | 0.02 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.71, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Medadvisor's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medadvisor is expected to be smaller as well. At this point, Medadvisor has a negative expected return of -0.99%. Please make sure to verify Medadvisor's variance, jensen alpha, and the relationship between the standard deviation and information ratio , to decide if Medadvisor performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Medadvisor has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Last Split Factor 1:7 | Last Split Date 2019-11-20 |
1 | MedAdvisor Limited Releases 2025 Annual Report - TipRanks | 10/08/2025 |
2 | MedAdvisor Limited Announces New Securities Quotation on ASX - MSN | 11/05/2025 |
3 | Analysts Are Optimistic Well See A Profit From MedAdvisor Limited - Yahoo Finance | 11/11/2025 |
4 | MedAdvisor Limiteds FY25 AGM Highlights Business Prospects Amidst Market Uncertainties - TipRanks | 11/25/2025 |
| Begin Period Cash Flow | 15.6 M | |
| Total Cashflows From Investing Activities | -2.2 M |
Medadvisor |
Medadvisor Relative Risk vs. Return Landscape
If you would invest 4.20 in Medadvisor on October 2, 2025 and sell it today you would lose (2.20) from holding Medadvisor or give up 52.38% of portfolio value over 90 days. Medadvisor is producing return of less than zero assuming 6.2341% volatility of returns over the 90 days investment horizon. Simply put, 55% of all stocks have less volatile historical return distribution than Medadvisor, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Medadvisor Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medadvisor's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medadvisor, and traders can use it to determine the average amount a Medadvisor's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1592
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MDR |
Estimated Market Risk
| 6.23 actual daily | 55 55% of assets are less volatile |
Expected Return
| -0.99 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Medadvisor is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medadvisor by adding Medadvisor to a well-diversified portfolio.
Medadvisor Fundamentals Growth
Medadvisor Stock prices reflect investors' perceptions of the future prospects and financial health of Medadvisor, and Medadvisor fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medadvisor Stock performance.
| Return On Equity | -2.41 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.96) % | ||||
| Operating Margin | (0.21) % | ||||
| Current Valuation | 19.82 M | ||||
| Shares Outstanding | 636.52 M | ||||
| Price To Book | 3.95 X | ||||
| Price To Sales | 0.22 X | ||||
| Revenue | 62.99 M | ||||
| Gross Profit | 3.97 M | ||||
| EBITDA | (11.93 M) | ||||
| Net Income | (60.21 M) | ||||
| Total Debt | 17.4 M | ||||
| Book Value Per Share | 0 X | ||||
| Cash Flow From Operations | (14.37 M) | ||||
| Earnings Per Share | (0.11) X | ||||
| Total Asset | 39.84 M | ||||
| Retained Earnings | (132.3 M) | ||||
About Medadvisor Performance
Assessing Medadvisor's fundamental ratios provides investors with valuable insights into Medadvisor's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Medadvisor is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Medadvisor is entity of Australia. It is traded as Stock on AU exchange.Things to note about Medadvisor performance evaluation
Checking the ongoing alerts about Medadvisor for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medadvisor help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medadvisor generated a negative expected return over the last 90 days | |
| Medadvisor has high historical volatility and very poor performance | |
| Medadvisor has some characteristics of a very speculative penny stock | |
| Medadvisor has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 62.99 M. Net Loss for the year was (60.21 M) with profit before overhead, payroll, taxes, and interest of 3.97 M. | |
| Medadvisor generates negative cash flow from operations | |
| About 37.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Medadvisor's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medadvisor's stock is overvalued or undervalued compared to its peers.
- Examining Medadvisor's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medadvisor's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medadvisor's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medadvisor's stock. These opinions can provide insight into Medadvisor's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Medadvisor Stock Analysis
When running Medadvisor's price analysis, check to measure Medadvisor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medadvisor is operating at the current time. Most of Medadvisor's value examination focuses on studying past and present price action to predict the probability of Medadvisor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medadvisor's price. Additionally, you may evaluate how the addition of Medadvisor to your portfolios can decrease your overall portfolio volatility.